Celldex Therapeutics
The Senior Director, Epidemiology, Immunology at Celldex will lead the development and execution of epidemiology and real‑world evidence strategies for the company’s immunology portfolio, supporting clinical development, regulatory submissions, safety, medical affairs, payer engagement, and commercialization. The role involves designing and overseeing high‑quality observational studies, collaborating with cross‑functional teams, and representing Celldex in scientific forums.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
12% above the average for this role